Table 1. Summary of subject characteristics at diagnosis and p16/INK4A immunohistochemistry data (n=88).
| Male (n=72) | Female (n=16) | All (n=88) | |
|---|---|---|---|
|
Histology type, n (%) | |||
| Epithelioid | 56 (77.8) | 15 (93.7) | 71 (80.7) |
| Biphasic | 8 (11.1) | 1 (6.3) | 9 (10.2) |
| Sarcomatoid | 8 (11.1) | 0 (0) | 8 (9.1) |
|
Stages | |||
| T2 | 22 (30.6) | 5 (31.2) | 27 (30.7) |
| T3 | 40 (55.6) | 5 (31.2) | 45 (51.1) |
| T4 | 10 (13.8) | 6 (37.5) | 16 (18.2) |
|
Chemotherapy, n (%) | |||
| Yes | 51 (70.8) | 13 (81.3) | 64 (72.7) |
| No | 21 (29.2) | 3 (18.7) | 24 (27.3) |
|
p16 Expression | |||
| Negative/low | 39 (54.2) | 6 (37.5) | 45 (51.1) |
| Intermediate | 22 (30.5) | 6 (37.5) | 28 (31.8) |
| High | 11 (15.3) | 4 (25.0) | 15 (17.1) |
Values are expressed as n (%).